{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:44:02Z","timestamp":1792928642162,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.pcad.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T17:14:13Z","timestamp":1553534053000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":310,"title":["Diabetic cardiomyopathy - A comprehensive updated review"],"prefix":"10.1016","volume":"62","author":[{"given":"Ghulam","family":"Murtaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeez Ul Hassan","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhan","family":"Shanmugasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timir K.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2019.03.003_bb0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2019.03.003_bb0015","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","article-title":"Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options","volume":"121","author":"Aneja","year":"2008","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.pcad.2019.03.003_bb0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/eci.12673","article-title":"Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?","volume":"46","author":"Mizamtsidi","year":"2016","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.pcad.2019.03.003_bb0025","first-page":"10","article-title":"Clinical manifestations of diabetic cardiomyopathy","volume":"45","author":"Boudina","year":"2009","journal-title":"Heart Metab"},{"key":"10.1016\/j.pcad.2019.03.003_bb0030","doi-asserted-by":"crossref","unstructured":"Aneja A, Tang WW, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 2008; 121:748\u201357?","DOI":"10.1016\/j.amjmed.2008.03.046"},{"key":"10.1016\/j.pcad.2019.03.003_bb0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2019.03.003_bb0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2019.03.003_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0050","doi-asserted-by":"crossref","unstructured":"Bertero E, Maack C. Calcium Signaling and Reactive Oxygen Species in Mitochondria. Circulation Research. 2018; 122:1460\u20131478. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.310082.","DOI":"10.1161\/CIRCRESAHA.118.310082"},{"key":"10.1016\/j.pcad.2019.03.003_bb0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2013.02.030","article-title":"Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca2+ leak by reducing oxidative modification of ryanodine receptors","volume":"60","author":"Jiang","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pcad.2019.03.003_bb0060","doi-asserted-by":"crossref","unstructured":"Pierce GN, Ramjiawan B, Dhalla NS, Ferrari R (1990) Na+ -H+ exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Phys 258:H255\u2013H261?","DOI":"10.1152\/ajpheart.1990.258.1.H255"},{"key":"10.1016\/j.pcad.2019.03.003_bb0065","doi-asserted-by":"crossref","unstructured":"Makino N, Dhalla KS, ElimbanV DNS (1987) Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Phys 253:E202\u2013E207?","DOI":"10.1152\/ajpendo.1987.253.2.E202"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_bb0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jacc.2005.09.030","article-title":"Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus","volume":"47","author":"Herrero","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0080","doi-asserted-by":"crossref","unstructured":"Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2005 May 15; 1734(2):112\u201326.","DOI":"10.1016\/j.bbalip.2005.03.005"},{"key":"10.1016\/j.pcad.2019.03.003_bb0085","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","article-title":"Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness","volume":"124","author":"Falc\u00e3o-Pires","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.03.003_bb0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41598-017-00627-5","article-title":"Fibrosis quantification in hypertensive heart disease with LVH and non-LVH: findings from T1 mapping and contrast-free cardiac diffusion-weighted imaging","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0100","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ki.1996.162","article-title":"Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus","volume":"49","author":"Iwano","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2019.03.003_bb0105","doi-asserted-by":"crossref","unstructured":"Dennler S., Ten Dijke P. Smad Proteins in TGF-Beta Signaling. In: Schwab M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/978-3-642-16483-5_5364.","DOI":"10.1007\/978-3-642-16483-5_5364"},{"key":"10.1016\/j.pcad.2019.03.003_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11010-006-9401-6","article-title":"High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellularsignal-regulated kinase 1\/2","volume":"301","author":"Tang","year":"2007","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0115","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0120","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/diacare.22.7.1186","article-title":"Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes","volume":"22","author":"Berg","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","article-title":"Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes","volume":"21","author":"Aronson","year":"2003","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","article-title":"Cellular death, reactive oxygen species (ROS) and diabetic complications","volume":"9","author":"Volpe","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pcad.2019.03.003_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/CT:1:3:181","article-title":"Oxidative stress and diabetic cardiomyopathy: a brief review","volume":"1","author":"Cai","year":"2001","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-8-8","article-title":"The signal transduction pathway of PKC\/NF-kappa B\/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats","volume":"8","author":"Min","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pcad.2019.03.003_bb0150","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jcmg.2010.09.014","article-title":"Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes","volume":"3","author":"Sacre","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.03.003_bb0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000184117","article-title":"Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure","volume":"45","author":"Axelrod","year":"1987","journal-title":"Nephron"},{"key":"10.1016\/j.pcad.2019.03.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8917578","article-title":"Update on RAAS modulation for the treatment of diabetic cardiovascular disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.pcad.2019.03.003_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2016.11.013","article-title":"Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy","volume":"102","author":"Li","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcme.2014.08.007","article-title":"Coronary microvascular dysfunction in overt diabetic cardiomyopathy","volume":"5","author":"Bratis","year":"2014","journal-title":"IJC Metab Endocr"},{"key":"10.1016\/j.pcad.2019.03.003_bb0175","unstructured":"H.A. Hadi, J.A. Suwaidi Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag, 3 (6) (2007), pp. 853\u2013876."},{"key":"10.1016\/j.pcad.2019.03.003_bb0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2001.113215","article-title":"Utility of B-natriuretic peptide (BNP) as a rapid, point-of-care test for screening patients undergoing echocardiography for left ventricular dysfunction","volume":"141","author":"Maisel","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.03.003_bb0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ijcard.2015.03.436","article-title":"Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: the Atherosclerosis Risk in Communities Cohort Study","volume":"187","author":"McEvoy","year":"2015","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2019.03.003_bb0190","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(01)01230-X","article-title":"The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study","volume":"37","author":"Liu","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2019.03.003_bb0195","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2006.07.020","article-title":"Can technical limitations of strain rate imaging be overtaken by particular arrangements?","volume":"48","author":"Galderisi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.pcad.2019.03.003_bb0200","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.0000015076.37047.D9","article-title":"Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study","volume":"105","author":"Bella","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0195-668X(02)00428-1","article-title":"Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample","volume":"24","author":"Fischer","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_bb0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9149(00)01366-7","article-title":"Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus","volume":"87","author":"Zabalgoitia","year":"2001","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0735-1097(96)81240-X","article-title":"A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography","volume":"27","author":"Takatsuji","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2019.03.003_bb0220","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0002-9149(03)00414-4","article-title":"Relation of hemoglobin A1C to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease","volume":"91","author":"Shishehbor","year":"2003","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2019.03.003_bb0225","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2019.03.003_bb0230","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2019.03.003_bb0235","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1464-5491.2005.01685.x","article-title":"Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging","volume":"22","author":"Bonito","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.pcad.2019.03.003_bb0240","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2015.12.001","article-title":"Early cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging","volume":"90","author":"Shepherd","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2019.03.003_bb0245","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ejechocard\/jep097","article-title":"Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration","volume":"10","author":"Nakai","year":"2009","journal-title":"Eur J Echocardiogr"},{"issue":"8","key":"10.1016\/j.pcad.2019.03.003_bb0250","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiac magnetic resonance","volume":"57","author":"Nathan","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrcardio.2014.159","article-title":"Cardiac MRI: a central prognostic tool in myocardial fibrosis","volume":"12","author":"Ambale-Venkatesh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0260","doi-asserted-by":"crossref","unstructured":"Kwong, Raymond Y. et al. \u201cIncidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Patients without Clinical Evidence of Myocardial Infarction.\u201d Circulation 118.10 (2008): 1011\u20131020. PMC. Web. 16 May 2018.","DOI":"10.1161\/CIRCULATIONAHA.107.727826"},{"key":"10.1016\/j.pcad.2019.03.003_bb0265","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2013.10.084","article-title":"Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness","volume":"63","author":"Ellims","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 mapping in characterizing myocardial disease: a comprehensive review","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2019.03.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9584278","article-title":"Assessment of diabetic cardiomyopathy by cardiovascular magnetic resonance T1 mapping: correlation with left-ventricular diastolic dysfunction and diabetic duration","volume":"2017","author":"Shang","year":"2017","journal-title":"J Diabetes Res"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_bb0280","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.numecd.2009.08.013","article-title":"Perspectives of nuclear diagnostic imaging in diabetic cardiomyopathy","volume":"20","author":"Sasso","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2019.03.003_bb0285","doi-asserted-by":"crossref","first-page":"H292","DOI":"10.1152\/ajpheart.01362.2006","article-title":"Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis","volume":"293","author":"Marsh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2840-8-39","article-title":"Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography","volume":"8","author":"van den Brom","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"16","key":"10.1016\/j.pcad.2019.03.003_bb0295","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"Rijzewijk","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2019.03.003_bb0300","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02766802","article-title":"A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension","volume":"12","author":"Kawaguchi","year":"1997","journal-title":"Heart Vessel"},{"key":"10.1016\/j.pcad.2019.03.003_bb0305","series-title":"Endomyocardial Biopsy in Diabetic Cardiomyopathy Procedure, Clinico-Pathological & Structural Functional Correlation","author":"Das","year":"1995"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_bb0310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/CT:3:3:219","article-title":"Cell death and diabetic cardiomyopathy","volume":"3","author":"Cai","year":"2003","journal-title":"Cardiovasc Toxicol"},{"issue":"12","key":"10.1016\/j.pcad.2019.03.003_bb0315","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Frustaci","year":"2000","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0320","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0325","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0895-4356(99)00135-3","article-title":"Vital epidemiologic clues in heart failure","volume":"53","author":"Kannel","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0330","unstructured":"Chae CU, Glynn RJ, Manson JE, Guralnik JM, Taylor JO, Pfeffer MA. Diabetes predicts congestive heart failure risk in the elderly. Circulation 1998; 98 (Suppl I): 721."},{"issue":"10","key":"10.1016\/j.pcad.2019.03.003_bb0335","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"issue":"13","key":"10.1016\/j.pcad.2019.03.003_bb0340","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1974.03230510023016","article-title":"Diabetic cardiomyopathy","volume":"229","author":"Hamby","year":"1974","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.pcad.2019.03.003_bb0360","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1463-1326.2007.00803.x","article-title":"Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes","volume":"10","author":"Brooks","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0975-3583.89805","article-title":"Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function","volume":"2","author":"Patil","year":"2011","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1016\/j.pcad.2019.03.003_bb0370","article-title":"H\u00f8ilund\u2013Carlsen PF, Beck-Nielsen H, M\u00f8ller JE. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease","volume":"CIRCIMAGING-109","author":"Poulsen","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_bb0375","first-page":"249","article-title":"Diastolic dysfunction in diabetes mellitus","volume":"3","author":"Dikshit","year":"2013","journal-title":"Natl J Med Res"},{"issue":"5","key":"10.1016\/j.pcad.2019.03.003_bb0380","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","article-title":"The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota","volume":"20","author":"Dandamudi","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2019.03.003_bb0385","series-title":"Abstract P355: Prevalence of Diastolic Dysfunction With Preserved Left Ventricular Systolic Function in Hypertensive and Type II Diabetic Patients in a Large Community Practice in Greenville, South Carolina","author":"Saxena","year":"2017"},{"key":"10.1016\/j.pcad.2019.03.003_bb0390","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","article-title":"Glycaemic control and incidence of heart failure in 20985 patients with type 1 diabetes: an observational study","volume":"378","author":"Bounias","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2019.03.003_bb0395","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the Strong Heart Study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.03.003_bb0400","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0405","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ahj.2004.06.021","article-title":"Screening for heart disease in diabetic subjects","volume":"149","author":"Fang","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.03.003_bb0410","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000130845.38133.8F","article-title":"Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction. A community-based study","volume":"109","author":"Redfield","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2019.03.003_bb0415","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/eurjhf\/hfq110","article-title":"Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome","volume":"12","author":"Kiencke","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.pcad.2019.03.003_bb0420","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005539","article-title":"Diabetes mellitus, microalbuminuria, and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure","volume":"6","author":"Swoboda","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0425","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cdt.2018.01.03","article-title":"Echocardiographic feature of diabetic cardiomyopathy: where are we now?","volume":"8","author":"Negishi","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.pcad.2019.03.003_bb0430","doi-asserted-by":"crossref","unstructured":"A Thandavarayan R, V Giridharan V, Watanabe K, Konishi T. Diabetic cardiomyopathy and oxidative stress: role of antioxidants. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Cardiovascular & Hematological Agents). 2011 Oct 1; 9(4):225\u201330.","DOI":"10.2174\/187152511798120877"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0435","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157340308786349453","article-title":"Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants","volume":"4","author":"Hill","year":"2008","journal-title":"Curr Cardiol Rev"},{"issue":"10","key":"10.1016\/j.pcad.2019.03.003_bb0440","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.2337\/db06-0456","article-title":"Vitamin E and risk of type 2 diabetes in the Women's Health Study randomized controlled trial","volume":"55","author":"Liu","year":"2006","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.pcad.2019.03.003_bb0445","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/hq0801.095084","article-title":"Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis","volume":"21","author":"Heinecke","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0450","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.freeradbiomed.2015.04.028","article-title":"Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K (p110\u03b1) signaling","volume":"87","author":"De Blasio","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pcad.2019.03.003_bb0455","doi-asserted-by":"crossref","unstructured":"Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP, Q-SYMBIO study investigators. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC: Heart Failure. 2014 Dec 1; 2(6):641\u20139.","DOI":"10.1016\/j.jchf.2014.06.008"},{"key":"10.1016\/j.pcad.2019.03.003_bb0460","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.recesp.2016.04.025","article-title":"PI3K\u03b3 inhibition protects against diabetic cardiomyopathy in mice","volume":"70","author":"Maffei","year":"2017","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI62876","article-title":"MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment","volume":"123","author":"Quiat","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2019.03.003_bb0470","doi-asserted-by":"crossref","unstructured":"Rodino-Klapac LR. MicroRNA based treatment of cardiomyopathy: not all dystrophies are created equal. JAHA 2013. 2:e000384. https:\/\/doi.org\/10.1161\/JAHA.113.000384.","DOI":"10.1161\/JAHA.113.000384"},{"issue":"5","key":"10.1016\/j.pcad.2019.03.003_bb0475","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FJC.0000000000000562","article-title":"Vaspin prevents tumor necrosis factor-\u03b1\u2013induced apoptosis in cardiomyocytes by promoting autophagy","volume":"71","author":"Ke","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0480","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/jc.2015-3292","article-title":"A diet rich in medium-chain fatty acids improves systolic function and alters the lipidomic profile in patients with type 2 diabetes: a pilot study","volume":"101","author":"Airhart","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2019.03.003_bb0485","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2007-985154","article-title":"Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy","volume":"116","author":"Zhang","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pcad.2019.03.003_bb0490","doi-asserted-by":"crossref","unstructured":"Asahara T, Kawamoto A, Masuda H. Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29(11):1650\u20131655. doi: https:\/\/doi.org\/10.1002\/stem.745.","DOI":"10.1002\/stem.745"},{"key":"10.1016\/j.pcad.2019.03.003_bb0495","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/16.suppl_O.107","article-title":"The renin-angiotensin-aldosterone system and myocardial collagen matrix remodeling in congestive heart failure","volume":"16","author":"Brilla","year":"1995","journal-title":"Eur Heart J"},{"issue":"9215","key":"10.1016\/j.pcad.2019.03.003_bb0500","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0505","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ejhf.474","article-title":"LCZ696, an angiotensin receptor\u2013neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice","volume":"18","author":"Suematsu","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2019.03.003_bb0510","doi-asserted-by":"crossref","unstructured":"Brandenburg VM, Rocca HB, Marx N. Sacubitril\/Valsartan in patients with diabetes and heart failure. Deutsche Medizinische Wochenschrift (1946). 2016 Oct;141(22):1647\u20139.","DOI":"10.1055\/s-0042-000001"},{"issue":"22","key":"10.1016\/j.pcad.2019.03.003_bb0515","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0520","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/01.CIR.101.2.122","article-title":"Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids","volume":"101","author":"Dandona","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_bb0525","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0033-0620(98)80030-3","article-title":"\u03b2-Adrenergic blockade in chronic heart failure: principles, progress, and practice","volume":"41","author":"Packer","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_rf0450","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.pcad.2019.03.003_rf0455","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCRESAHA.114.301958","article-title":"Cardiovascular actions of incretin-based therapies","volume":"114","author":"Ussher","year":"2014","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.pcad.2019.03.003_rf0460","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_rf0465","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/XCE.0000000000000086","article-title":"Incretin-based therapies for the failing heart","volume":"5","author":"Ussher","year":"2016","journal-title":"Cardiovasc Endocrinol"},{"issue":"1","key":"10.1016\/j.pcad.2019.03.003_rf0470","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0891-6632(90)90057-C","article-title":"Hyperkalemia in diabetes mellitus","volume":"4","author":"Uribarri","year":"1990","journal-title":"J Diabet Complicat"},{"issue":"3","key":"10.1016\/j.pcad.2019.03.003_rf0475","first-page":"H1096","article-title":"Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure","volume":"298","author":"Halbirk","year":"2010","journal-title":"Am J Phys Heart Circ Phys"},{"key":"10.1016\/j.pcad.2019.03.003_bb0545","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.03.003_bb0550","first-page":"1","article-title":"The vildagliptin in ventricular dysfunction diabetes trial (VIVIDD)","volume":"12","author":"McMurray","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0555","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1440-1681.2010.05470.x","article-title":"Metformin improves cardiac function in rats via activation of AMP-activated protein kinase","volume":"38","author":"Wang","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pcad.2019.03.003_bb0560","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ihj.2017.05.009","article-title":"Metformin in heart failure patients","volume":"70","author":"Kinsara","year":"2018","journal-title":"Indian Heart J"},{"key":"10.1016\/j.pcad.2019.03.003_bb0565","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12933-014-0152-5","article-title":"Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis","volume":"13","author":"Eriksson","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.pcad.2019.03.003_bb0570","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","article-title":"Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus","volume":"106","author":"Haffner","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0575","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2015.12.003","article-title":"Update on obesity and obesity paradox in heart failure","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"issue":"23","key":"10.1016\/j.pcad.2019.03.003_bb0580","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.03.003_bb0585","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-157-9-201211060-00003","article-title":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study","volume":"157","author":"Roumie","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.pcad.2019.03.003_bb0590","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005379","article-title":"Comparative safety of sulfonylurea and metformin monotherapy on the risk of heart failure: a cohort study","volume":"6","author":"Roumie","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.pcad.2019.03.003_bb0595","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pcad.2019.03.003_bb0600","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Look AHEAD Research Group","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019300519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019300519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:15:29Z","timestamp":1758500129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062019300519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0033062019300519"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2019.03.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic cardiomyopathy - A comprehensive updated review","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}